Microchip Shares Slide 1.43% on $550M Volume in 143th Market Activity as Credit Agricole Cuts Stake 81.1% and Others Boost Holdings

Generated by AI AgentAinvest Market Brief
Wednesday, Aug 27, 2025 9:40 pm ET1min read
Aime RobotAime Summary

- Microchip shares fell 1.43% to $69.14 on $550M volume, ranking 143th in market activity.

- Credit Agricole cut its stake by 81.1%, while Banco Bilbao and Watts Gwilliam boosted holdings by 22.6% and 128.6%.

- Q2 revenue hit $1.08B (13.3% YoY decline), with a -3.50% net margin and $0.455 dividend yielding 2.6%.

- Analysts revised targets (Mizuho to $85, Zacks to "hold"), while insider Matthew Chapman sold 10,000 shares.

- Institutional ownership at 91.51%, with a -535.29% payout ratio highlighting operational challenges.

On August 27, 2025,

(MCHP) fell 1.43% to $69.14, with a trading volume of $0.55 billion, ranking 143rd in market activity. Institutional investor Credit Agricole S A slashed its stake by 81.1% in Q1, retaining $1.46 million worth of shares. Meanwhile, several institutional investors increased holdings, including Banco Bilbao Vizcaya Argentaria S.A. and Watts Gwilliam & Co. LLC, boosting their positions by 22.6% and 128.6%, respectively. Institutional ownership now accounts for 91.51% of the stock.

The company reported Q2 2025 revenue of $1.08 billion, exceeding expectations but reflecting a 13.3% year-over-year decline. Despite a negative net margin of 3.50%, the firm announced a quarterly dividend of $0.455 per share, yielding 2.6% annually. Analysts have revised earnings targets, with

upgrading its price target to $85 and Raymond James to $75, while Zacks downgraded to "hold." The stock maintains a "Moderate Buy" consensus rating with a $76.58 average target.

Insider activity included a sale by Matthew Chapman, who offloaded 10,000 shares. Financial metrics highlight a market cap of $37.31 billion, a P/E ratio of -203.35, and a beta of 1.55. The dividend payout ratio remains highly negative at -535.29%, underscoring operational challenges.

The backtest results include unrelated developments: ENGO Eyewear launched its ENGO 2 smart glasses, Healthy Extracts expanded its

product line, and faces a class-action lawsuit. These items reflect broader market dynamics but do not directly impact Microchip’s stock performance.

Comments



Add a public comment...
No comments

No comments yet